<!doctype html>
<title>Health</title>
<script>
function rgb2hsv (r, g, b) {
    let rabs, gabs, babs, rr, gg, bb, h, s, v, diff, diffc, percentRoundFn;
    rabs = r / 255;
    gabs = g / 255;
    babs = b / 255;
    v = Math.max(rabs, gabs, babs),
    diff = v - Math.min(rabs, gabs, babs);
    diffc = c => (v - c) / 6 / diff + 1 / 2;
    percentRoundFn = num => Math.round(num * 100) / 100;
    if (diff == 0) {
        h = s = 0;
    } else {
        s = diff / v;
        rr = diffc(rabs);
        gg = diffc(gabs);
        bb = diffc(babs);

        if (rabs === v) {
            h = bb - gg;
        } else if (gabs === v) {
            h = (1 / 3) + rr - bb;
        } else if (babs === v) {
            h = (2 / 3) + gg - rr;
        }
        if (h < 0) {
            h += 1;
        }else if (h > 1) {
            h -= 1;
        }
    }
    return {
        h: Math.round(h * 360),
        s: percentRoundFn(s * 100),
        v: percentRoundFn(v * 100)
    };
}
function isGreen(r,g,b){
  h = rgb2hsv(r,g,b).h;
  if(h >= 69 && h <= 181){
    return (true);
  }
  return false;
}
function hexToRgb(hex) {
  var result = /^#?([a-f\d]{2})([a-f\d]{2})([a-f\d]{2})$/i.exec(hex);
  return result ? {
    r: parseInt(result[1], 16),
    g: parseInt(result[2], 16),
    b: parseInt(result[3], 16)
  } : null;
}
function getRandomColor() {
  var letters = '0123456789ABCDEF';
  var color = '#';
  for (var i = 0; i < 6; i++) {
    color += letters[Math.floor(Math.random() * 16)];
  }
  var colors = hexToRgb(color);
  if(isGreen(colors.r,colors.g,colors.b)){
    return getRandomColor(); 
  }
  return color;
}
function graph(t){
  t.style.borderCollapse='collapse';
  t=t.rows[0];
  for(var i=0;i<t.children.length;i++){
    t.children[i].style.textAlign = 'center';
    t.children[i].innerHTML = "<div style='display:inline-block;background:"+getRandomColor()+";width:20px;height:"+t.children[i].innerHTML+"px'></div><br>"+t.children[i].innerHTML;
    t.children[i].style.verticalAlign = 'bottom';
  }
}
window.onload = function(){
  var t = document.getElementsByClassName('bargraph');
  for(var i=0;i<t.length;i++)graph(t[i]);
  
}
</script><pre>
Who gives deliveries in the delivery room female nurses
and female doctors

Zyprexa->Serouel->Risperdal->Abilify Maintena

Patrick Soon-Shiong    $7.3 billion
Thomas Frist           $4 billion
Gayle Cook             $3.7 billion
Ronda Stryker          $2.5 billion
Faulkner               $1.7 billion

<a href="https://www.athenahealth.com/insight/healthcare-future-female">Healthcare future is female</a>
<a href="https://www.statista.com/chart/14983/female-doctors-by-country/">Female Doctors By Country</a>

<h1>Health Care</h1><p>
How do I make any supplement into liquid?
<img style="width:400px;" src="https://hitconsultant.net/wp-content/uploads/2014/07/Top-5-Most-Widely-Used-EHRs-by-Physicians.jpg">
</p>
<a href="https://en.wikipedia.org/wiki/Richmond_Agitation-Sedation_Scale">RASS</a>
<img src="https://stahlonline.cambridge.org/content/ep4/images/02598fig5_7.png" width=400>

Names of antipsychotics | nuerotoxins, antipsychotics, neuroleptics

extrapyramidal symptoms include acute dyskinesias and dystonic reactions, tardive dyskinesia, Parkinsonism, akinesia, akathisia, and neuroleptic malignant syndrome
<a href="http://clincalc.com/PronounceTop200Drugs/">Top Drugs</a>
<table summary="Results - COMPREHENSIVE METABOLIC PANEL - Final result (04/13/2018 11:41 AM)">
                  <colgroup>
                    <col style="width:25%">
                    <col style="width:50%">
                    <col style="width:25%">
                  </colgroup>
                  <thead>
                    <tr class="SRonly">
                      <th colspan="3" scope="colgroup">COMPREHENSIVE METABOLIC PANEL - Final result (04/13/2018 11:41 AM)</th>
                    </tr>
                    <tr>
                      <th>Component</th>
                      <th>Value</th>
                      <th>Ref Range</th>
                    </tr>
                  </thead>
                  <tbody>
                    <tr class="TableRow" id="Result434017075Comp1">
                      <td id="Result434017075Comp1Name">Sodium(na)</td>
                      <td>138</td>
                      <td>135 - 146 MMOL/L</td>
                    </tr>
                    <tr class="alt TableRow" id="Result434017075Comp2">
                      <td id="Result434017075Comp2Name">Potassium(k)</td>
                      <td><span>4.1</span><span class="allIndent"><span class="cellHeader">Comment: </span><span id="Result434017075Comp2Comment">NO VISIBLE HEMOLYSIS</span></span></td>
                      <td>3.5 - 5.3 MMOL/L</td>
                    </tr>
                    <tr class="TableRow" id="Result434017075Comp3">
                      <td id="Result434017075Comp3Name">Chloride(chloide)</td>
                      <td>104</td>
                      <td>98 - 110 MMOL/L</td>
                    </tr>
                    <tr class="alt TableRow" id="Result434017075Comp4">
                      <td id="Result434017075Comp4Name">CO2</td>
                      <td>26</td>
                      <td>21 - 33 MMOL/L</td>
                    </tr>
                    <tr class="TableRow" id="Result434017075Comp5">
                      <td id="Result434017075Comp5Name">BUN
				<br>Blood urea nitrogen
				<div data-local-attribute="d3bn" data-ved="2ahUKEwiv-N6J4LzcAhUS2lMKHe7SBXEQ3B0oATAeegQICxAN"></div>
			</td>
                      <td>15</td>
                      <td>8 - 24 MG/DL</td>
                    </tr>
                    <tr class="alt TableRow" id="Result434017075Comp6">
                      <td id="Result434017075Comp6Name">Glucose(C<sub>6</sub>H<sub>12</sub>O<sub>6)</sub></td>
                      <td>85</td>
                      <td>70 - 99 MG/DL</td>
                    </tr>
                    <tr class="TableRow" id="Result434017075Comp7">
                      <td id="Result434017075Comp7Name">Creatinine</td>
                      <td>0.98</td>
                      <td>0.50 - 1.50 MG/DL</td>
                    </tr>
                    <tr class="alt TableRow" id="Result434017075Comp8">
                      <td id="Result434017075Comp8Name">Calcium(Ca)</td>
                      <td>9.7</td>
                      <td>8.5 - 10.5 MG/DL</td>
                    </tr>
                    <tr class="TableRow" id="Result434017075Comp9">
                      <td id="Result434017075Comp9Name">Total Protein</td>
                      <td>7.0</td>
                      <td>6.0 - 8.3 G/DL</td>
                    </tr>
                    <tr class="alt TableRow" id="Result434017075Comp10">
                      <td id="Result434017075Comp10Name">Albumin </td>
                      <td>4.7</td>
                      <td>3.5 - 5.0 G/DL</td>
                    </tr>
                    <tr class="TableRow" id="Result434017075Comp11">
                      <td id="Result434017075Comp11Name">Total Bilirubin</td>
                      <td>0.5</td>
                      <td>0.1 - 1.2 MG/DL</td>
                    </tr>
                    <tr class="alt TableRow" id="Result434017075Comp12">
                      <td id="Result434017075Comp12Name">Alkaline Phosphatase</td>
                      <td>53</td>
                      <td>25 - 125 IU/L</td>
                    </tr>
                    <tr class="TableRow" id="Result434017075Comp13">
                      <td id="Result434017075Comp13Name">AST (SGOT)</td>
                      <td>21</td>
                      <td>5 - 40 IU/L</td>
                    </tr>
                    <tr class="alt TableRow" id="Result434017075Comp14">
                      <td id="Result434017075Comp14Name">ALT (SGPT)</td>
                      <td>36</td>
                      <td>5 - 50 IU/L</td>
                    </tr>
                    <tr class="TableRow" id="Result434017075Comp15">
                      <td id="Result434017075Comp15Name">Anion Gap</td>
                      <td>8</td>
                      <td>4 - 14 MMOL/L</td>
                    </tr>
                    <tr class="alt TableRow" id="Result434017075Comp16">
                      <td id="Result434017075Comp16Name">Est. GFR Non-Black</td>
                      <td><span>&gt;60</span><br><span class="allIndent"><span class="cellHeader">Comment: </span><br><span class="monospace" id="Result434017075Comp16Comment"><br>GFR is calculated by IDMS traceable MDRD method, and the result is about 5% lower than previously reported results (prior to Dec 12, 2011).<br></span></span></td>
                      <td>&nbsp;</td>
                    </tr>
                    <tr id="Result434017075Comp17">
                      <td id="Result434017075Comp17Name">Est. GFR Black</td>
                      <td><span>&gt;60</span><br><span class="allIndent"><span class="cellHeader">Comment: </span><br><span class="monospace" id="Result434017075Comp17Comment"><br>GFR is calculated by IDMS traceable MDRD method, and the result is about 5% lower than previously reported results (prior to Dec 12, 2011).<br></span></span></td>
                      <td>&nbsp;</td>
                    </tr>
                    <tr id="Result405894532Comp1">
                      <td id="Result405894532Comp1Name">Triglycerides</td>
                      <td>324 (01/15/2016)</td>
                      <td>&lt;150 MG/DL</td>
                    </tr>
                  </tbody>
                </table>
<div>OCT 02 2017</div><a href="https://www.labcorp.com/help/patient-test-info/thyroid-panel">Thyroid Panels</a><pre>
Cholesterol, Total    105NORMAL
Triglycerides         137NORMAL
HDL Cholesterol       28
VLDL Cholesterol Cal  27
LDL Cholesterol Calc  50</pre>

<table><thead><tr><th>TSH</th><th>T4</th><th>T3</th><th>Interpretation</th></tr></thead><tbody><tr><td>High</td>
<td>Normal</td>
<td>Normal</td>
<td>Mild (subclinical) hypothyroidism</td>
</tr><tr><td>High</td>
<td>Low</td>
<td>Low or normal</td>
<td>Hypothyroidism</td>
</tr><tr><td>Low</td>
<td>Normal</td>
<td>Normal</td>
<td>Mild (subclinical) hyperthyroidism</td>
</tr><tr><td>Low</td>
<td>High or normal</td>
<td>High or normal</td>
<td>Hyperthyroidism</td>
</tr><tr><td>Low</td>
<td>Low or normal</td>
<td>Low or normal</td>
<td>Nonthyroidal illness; pituitary (secondary) hypothyroidism</td>
</tr><tr><td>Normal</td>
<td>High</td>
<td>High</td>
<td>Thyroid hormone resistance syndrome (a mutation in the thyroid hormone receptor decreases thyroid hormone function)</td>
</tr></tbody></table>
<p>Pet Scan radioactive particles vs MRI scan</p>
<p><b>10 Most Prescribed Psychiatric Drugs in the the U.S. (in millions)</b></p>
<table border="1" cellspacing="2" cellpadding="0" class="bargraph">
	<tr>
		<td>44</td>
		<td>14</td>
		<td>15</td>
		<td>16</td>
		<td>18</td>
		<td>19</td>
		<td>19</td>
		<td>27</td>
		<td>14</td>
	</tr>
	<tr>
		<td>Xanax</td>
		<td>Valium/<br>
			Diazepam</td>
		<td>Seroquel<br>
    (antipsychotic)</td>
		<td>Cymbalta<br>(antidepressant)</td>
		<td>Trazodone<br>(antidepressant)</td>
		<td>Prozac</td>
		<td>Zoloft</td>
		<td>Lexapro</td>
		<td>Effexor</td>
	</tr>
</table>
<p><b>Top 10 Psychiatric Drugs by primary mechanism</b></p>
<table border="1" cellspacing="2" cellpadding="0" class="bargraph">
	<tr>
		<td>15</td>
		<td>66</td>
		<td>31</td>
		<td>83</td>
		<td>18</td>
	</tr>
	<tr>
		<td>Antipsychotic</td>
		<td>SSRI</td>
		<td>SNRI</td>
		<td>Benzo-diazepene</td>
		<td>5-T2A Blocker &amp; SSRI</td>
	</tr>
</table>
<p><b>Weight gain from antipsychotic drugs after 2.5 months (in pounds)</b></p>
<table border="1" cellspacing="2" cellpadding="0" class="bargraph">
	<tr>
		<td>-2.0</td>
		<td>-.7</td>
		<td>.2</td>
		<td>.9</td>
		<td>1.5</td>
		<td>1.9</td>
		<td>2.4</td>
		<td>4.6</td>
		<td>5.0</td>
		<td>6.5</td>
		<td>7.0</td>
		<td>9.2</td>
		<td>9.9</td>
	</tr>
	<tr>
		<td>Placebo</td>
		<td>Moban</td>
		<td>Geodon</td>
		<td>Permitil</td>
		<td>Abilify</td>
		<td>Solian</td>
		<td>Haldol</td>
		<td>Risperdal</td>
		<td>Seroquel</td>
		<td>Serdolect</td>
		<td>Thorazine</td>
		<td>Zyprexa</td>
		<td>Clozapine</td>
	</tr>
</table>
<p><b>Most common medications for bipolar</b></p>
<table border="1" cellspacing="2" cellpadding="0" class="bargraph">
	<tr>
		<td>70.9</td>
		<td>53</td>
		<td>.30</td>
		<td>.8</td>
		<td>5.6</td>
		<td>5.8</td>
	</tr>
	<tr>
		<td>Mood Stabalizers</td>
		<td>Antipsychotics</td>
		<td>Antidepressants</td>
		<td>Anxiety</td>
		<td>Sleep</td>
		<td>Other</td>
	</tr>
</table>
<p>Tardive Dyskinesia risk</p>
<table border="1" cellspacing="2" cellpadding="0" class="bargraph">
	<tr>
		<td>39</td>
		<td>53</td>
	</tr>
	<tr>
		<td>atypical</td>
		<td>(out of 100%)typical</td>
	</tr>
</table>
<p>qtc</p>
<p>PCOS Polycystic ovary syndrome</p>
<img src=https://i.stack.imgur.com/ygsV9.png>
<p>Sedation
</p><p>
Qt interval prolongation

<ol>
  <li>Cardiac conditions such as bradycardia, myocardial infarction, or hearth failure</li>
  <li>Electrolyte distirbuances</li>
  <li>Female sex</li>
  <li>Genetic Polymorphisms</li>
  <li>Age older then 65 years old</li>
  <li>Congentital long QT syndrome or other inherited cardiac abnormalities</li>
  <li>Concomitant medications or diseases states that prolong QT interval or affect electrolytes</li>
  <li>history of Qt prolongation</li>
</ol>
<b>Atypical Antipsychotics and Metabolic Effects</b></p>
<p>
<img src="data:image/jpeg;base64,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
"><br>
</p>
<p>Potency of different drugs</p>
<p>NMDA, GABA, </p>
<p>Serequel</p>
<p>Lipid Panel</p>
<table width="180" border="1" cellspacing="2" cellpadding="0">
	<tr>
		<td><figcaption>Cholesterol</figcaption></td>
		<td>150(100-199)</td>
	</tr>
	<tr>
		<td>Triglycerides</td>
		<td>137(0-149)</td>
	</tr>
	<tr>
		<td>HDL</td>
		<td>28</td>
	</tr>
	<tr>
		<td>VLDL</td>
		<td>27</td>
	</tr>
	<tr>
		<td>LDL</td>
		<td>50</td>
	</tr>
</table>
<table id="components688" class="components" summary="Table of test result components"><colgroup><col><col><col></colgroup><thead><tr><th title="Result Component" scope="col" id="components688_col0">Component</th><th title="Value of Component Result" scope="col" id="components688_col1">Your Value</th><th title="Range of Normal Values" scope="col" id="components688_col2">Standard Range</th></tr></thead><tbody><tr class="odd"><td class="nameCol srchbl" headers="components688_col0">LDL Direct</td><td class="valueCol" headers="components688_col1">121<span class="unit"> mg/dL</span></td><td class="rangeCol" headers="components688_col2">&lt;130 mg/dL</td></tr><tr><td class="nameCol srchbl" headers="components688_col0">Total Cholesterol</td><td class="valueCol" headers="components688_col1">180<span class="unit"> MG/DL</span></td><td class="rangeCol" headers="components688_col2">25 - 199 MG/DL</td></tr><tr class="odd"><td class="nameCol srchbl" headers="components688_col0">Triglycerides</td><td class="valueCol" headers="components688_col1">191<span class="unit"> MG/DL</span></td><td class="rangeCol" headers="components688_col2">10 - 150 MG/DL</td></tr><tr><td class="nameCol srchbl" headers="components688_col0">HDL Cholesterol</td><td class="valueCol" headers="components688_col1">29<span class="unit"> MG/DL</span></td><td class="rangeCol" headers="components688_col2">35 - 135 MG/DL</td></tr><tr class="odd"><td class="nameCol srchbl" headers="components688_col0">Total Chol / HDL Cholesterol</td><td class="valueCol" headers="components688_col1">6.2<span class="unit"> &nbsp;</span></td><td class="rangeCol" headers="components688_col2">&lt;4.5</td></tr><tr><td class="nameCol srchbl" headers="components688_col0">Non-HDL Cholesterol</td><td class="valueCol" headers="components688_col1">151<span class="unit"> MG/DL</span></td><td class="rangeCol" headers="components688_col2">MG/DL</td></tr><tr class="odd tableRowMessage comments"><td class="srchbl" colspan="3" headers="components688_col0">TARGET: &lt;(LDL-C TARGET + 30)MG/DL</td></tr><tr class="odd"><td class="nameCol srchbl" headers="components688_col0">Coronary Heart Disease Risk Table</td><td class="valueCol" headers="components688_col1">&nbsp;</td><td class="rangeCol" headers="components688_col2">&nbsp;</td></tr><tr class="tableRowMessage comments odd"><td class="srchbl" colspan="3" headers="components688_col0">TOTAL CHOLESTEROL/HDL RATIO:CHD RISK<br>CORONARY HEART DISEASE RISK TABLE<br><br>                    MEN     WOMEN<br>1/2 AVERAGE RISK    3.4      3.3<br>AVERAGE RISK        5.8      4.4<br>2 X AVERAGE RISK    9.6      7.1<br>3 X AVERAGE RISK    23.4     11.0<br><br>Use the calculated Patient Ratio and the CHD Risk Table to determine the patient's CHD Risk.<br><br>ATP III Classification (LDL):<br>&lt;100       mg/dl     Optimal<br>100-129    mg/dl     Near or Above Optimal<br>130-159    mg/dl     Borderline<br>160-189    mg/dl     High<br>&gt;190       mg/dl     Very High</td></tr></tbody></table>
<p>AB = 6<br>
	A = 2<br>
	B = 3<br>
	O = 5</p>
<table class="lists">
<tbody>
<tr>
<th colspan="12">Inherited Blood Type/Donor/Organ Donor/Blood Donation</th>
</tr>
<tr>
<td colspan="2"><b>Parent 1</b></td>
<td><b><span style="color: #961e1b;">AB</span></b></td>
<td><b><span style="color: #961e1b;">AB</span></b></td>
<td><b><span style="color: #961e1b;">AB</span></b></td>
<td><b><span style="color: #961e1b;">AB</span></b></td>
<td><b><span style="color: #961e1b;">B</span></b></td>
<td><b><span style="color: #961e1b;">A</span></b></td>
<td><b><span style="color: #961e1b;">A</span></b></td>
<td><b><span style="color: #961e1b;">O</span></b></td>
<td><b><span style="color: #961e1b;">O</span></b></td>
<td><b><span style="color: #961e1b;">O</span></b></td>
</tr>
<tr>
<td colspan="2"><b>Parent 2</b></td>
<td><b><span style="color: #961e1b;">AB</span></b></td>
<td><b><span style="color: #961e1b;">B</span></b></td>
<td><b><span style="color: #961e1b;">A</span></b></td>
<td><b><span style="color: #961e1b;">O</span></b></td>
<td><b><span style="color: #961e1b;">B</span></b></td>
<td><b><span style="color: #961e1b;">B</span></b></td>
<td><b><span style="color: #961e1b;">A</span></b></td>
<td><b><span style="color: #961e1b;">B</span></b></td>
<td><b><span style="color: #961e1b;">A</span></b></td>
<td><b><span style="color: #961e1b;">O</span></b></td>
</tr>
<tr>
<td colspan="2"><span style="color: #961e1b;"><b>O</b></span></td>
<td></td>
<td></td>
<td></td>
<td></td>
<td>+</td>
<td>+</td>
<td>+</td>
<td>+</td>
<td>+</td>
<td>+</td>
</tr>
<tr>
<td colspan="2"><span style="color: #961e1b;"><b>A</b></span></td>
<td>+</td>
<td>+</td>
<td>+</td>
<td style=background:orange>+</td>
<td></td>
<td>+</td>
<td>+</td>
<td></td>
<td>+</td>
<td></td>
</tr>
<tr>
<td colspan="2"><span style="color: #961e1b;"><b>B</b></span></td>
<td>+</td>
<td>+</td>
<td>+</td>
<td style=background:orange>+</td>
<td>+</td>
<td>+</td>
<td></td>
<td>+</td>
<td></td>
<td></td>
</tr>
<tr>
<td colspan="2"><span style="color: #961e1b;"><b>AB</b></span></td>
<td>+</td>
<td>+</td>
<td>+</td>
<td></td>
<td></td>
<td>+</td>
<td></td>
<td></td>
<td></td>
<td></td>
</tr>
</tbody>
</table>
<p>Overdose</p>
<table width="236" border="1" cellspacing="2" cellpadding="0">
	<tr>
		<td>13607.775mg</td>
		<td>450 mg</td>
		<td>2mg</td>
		<td>5g</td>
		<td></td>
		<td>800mg</td>
		<td>200mg</td>
		<td>75mg</td>
		<td>70mg</td>
		<td>21mg</td>
	</tr>
	<tr>
		<td>ambien(mg)</td>
		<td>zyperax(mg)</td>
		<td>fentanyl(mcg)</td>
		<td>lithium(450g)</td>
		<td>Carfentanil
			<div data-ved="2ahUKEwi-_sDp3bzcAhVDy1MKHUWnD6UQ3z4oAHoECA0QAw">
				<div>
					<div data-md="16" data-hveid="CA0QBA" data-ved="2ahUKEwi-_sDp3bzcAhVDy1MKHUWnD6UQhygwEnoECA0QBA">
						<div>
							<div aria-level="3" role="heading">
								<div data-local-attribute="d3bn" data-ved="2ahUKEwi-_sDp3bzcAhVDy1MKHUWnD6UQ3B0oATASegQIDRAN"></div>
							</div>
						</div>
					</div>
				</div>
			</div>
		</td>
		<td>Codeine</td>
		<td>morphine</td>
		<td>herion</td>
		<td>Vitamin A</td>
		<td>Vitamin D</td>
	</tr>
	<tr>
		<td>5mg</td>
		<td>5-10mg</td>
		<td></td>
		<td></td>
		<td></td>
		<td></td>
		<td></td>
		<td></td>
		<td></td>
		<td></td>
	</tr>
</table>
<p>Antipsychotic Side Effects By Receptors Blocked</p>
<table width="343" border="1" cellspacing="2" cellpadding="0">
	<tr>
		<td>Receptor Type</td>
		<td>Side Effects</td>
	</tr>
	<tr>
		<td>D<sub>2</sub></td>
		<td>EPS, prolactin elevation</td>
	</tr>
	<tr>
		<td>M<sub>1</sub></td>
		<td>Cognitive Deficits, dry mouth, constipation, increased heart rate, urinary retention, blured vision </td>
	</tr>
	<tr>
		<td>α<sub>1</sub></td>
		<td>hypotension</td>
	</tr>
	<tr>
		<td>5-HT<sub>2A</sub></td>
		<td>Anti-EPS?</td>
	</tr>
	<tr>
		<td>5-HT<sub>2C</sub></td>
		<td>Satiety blockade</td>
	</tr>
</table>
<p>D = dopamine, EPS = Extra Pyramidal Side Effects, M=muscarine, H=Histamine, 5-HT=serontonin</p>
<p></p>
<p>Diabetes insulin resistent</p>
<p></p>
<p><a href="https://www.statista.com/statistics/242494/leading-prescriptions-dispensed-antipsychotic-drugs-in-the-us/">Top antipsychotics prescribed 2011-2012</a></p>
<p>Mania</p>
<table width="431" border="1" cellspacing="2" cellpadding="0">
	<tr>
		<td></td>
		<td>EPS</td>
		<td>Sedation</td>
		<td>Weight</td>
		<td>Hyperlygemia</td>
		<td>Anticholinergic</td>
		<td>Othorstatic<br>
			hypotension</td>
		<td>TD</td>
		<td>Hyperprolactinemia </td>
		<td>diabetes</td>
		<td>cardiac arrhythmias</td>
		<td>torsades de pointes</td>
		<td>QTc</td>
	</tr>
	<tr>
		<td>Risperidone</td>
		<td>++</td>
		<td>++</td>
		<td>++</td>
		<td>++</td>
		<td>+</td>
		<td>++</td>
		<td></td>
		<td></td>
		<td>+/-</td>
		<td></td>
		<td>+</td>
		<td>low</td>
	</tr>
	<tr>
		<td>Seroquel</td>
		<td>-</td>
		<td>+</td>
		<td>++</td>
		<td>+++</td>
		<td>++</td>
		<td>++</td>
		<td></td>
		<td></td>
		<td>+/-</td>
		<td>-</td>
		<td>+</td>
		<td>2</td>
	</tr>
	<tr>
		<td>Olanzapine</td>
		<td>+</td>
		<td>+++</td>
		<td>+++</td>
		<td>+++</td>
		<td>+++</td>
		<td>+</td>
		<td></td>
		<td></td>
		<td>+</td>
		<td>-</td>
		<td>+</td>
		<td>low</td>
	</tr>
	<tr>
		<td>Clozapine</td>
		<td>+</td>
		<td>+++</td>
		<td>+++</td>
		<td>+++</td>
		<td>+++</td>
		<td>++</td>
		<td></td>
		<td></td>
		<td></td>
		<td></td>
		<td></td>
		<td></td>
	</tr>
	<tr>
		<td>Solian</td>
		<td>++</td>
		<td>+</td>
		<td>+</td>
		<td>+</td>
		<td>+</td>
		<td>+</td>
		<td></td>
		<td></td>
		<td></td>
		<td></td>
		<td></td>
		<td></td>
	</tr>
	<tr>
		<td>Abilify</td>
		<td>+</td>
		<td>+</td>
		<td>+</td>
		<td>+</td>
		<td>+</td>
		<td>+</td>
		<td></td>
		<td></td>
		<td></td>
		<td></td>
		<td>-</td>
		<td>-</td>
	</tr>
	<tr>
		<td>Geodon </td>
		<td>+</td>
		<td>++</td>
		<td>+</td>
		<td>+</td>
		<td>+</td>
		<td>++</td>
		<td></td>
		<td></td>
		<td></td>
		<td></td>
		<td></td>
		<td></td>
	</tr>
	<tr>
		<td>latuda</td>
		<td></td>
		<td></td>
		<td></td>
		<td></td>
		<td></td>
		<td></td>
		<td></td>
		<td></td>
		<td></td>
		<td></td>
		<td></td>
		<td></td>
	</tr>
	<tr>
		<td>haldol</td>
		<td></td>
		<td></td>
		<td></td>
		<td></td>
		<td></td>
		<td></td>
		<td></td>
		<td></td>
		<td></td>
		<td></td>
		<td></td>
		<td></td>
	</tr>
	<tr>
		<td>remeron</td>
		<td></td>
		<td></td>
		<td></td>
		<td></td>
		<td></td>
		<td></td>
		<td></td>
		<td></td>
		<td></td>
		<td></td>
		<td></td>
		<td>high</td>
	</tr>
	<tr>
		<td>elavil</td>
		<td></td>
		<td></td>
		<td></td>
		<td></td>
		<td></td>
		<td></td>
		<td></td>
		<td></td>
		<td></td>
		<td></td>
		<td></td>
		<td>4</td>
	</tr>
	<tr>
		<td>trazodone</td>
		<td></td>
		<td></td>
		<td></td>
		<td></td>
		<td></td>
		<td></td>
		<td></td>
		<td></td>
		<td></td>
		<td></td>
		<td></td>
		<td></td>
	</tr>
	<tr>
		<td>doxepin</td>
		<td></td>
		<td></td>
		<td></td>
		<td></td>
		<td></td>
		<td></td>
		<td></td>
		<td></td>
		<td></td>
		<td></td>
		<td></td>
		<td>1</td>
	</tr>
</table>
<p></p>
<table border="1" cellspacing="2" cellpadding="0" class="bargraph">
	<tr>
		<td>14</td>
		<td>14</td>
		<td>15</td>
		<td>17</td>
		<td>18</td>
		<td>24</td>
		<td>27</td>
		<td>32</td>
		<td>33</td>
		<td>33</td>
		<td>37</td>
		<td>38</td>
	</tr>
	<tr>
		<td>Solian</td>
		<td>Paliperidone</td>
		<td>Sertindole</td>
		<td>Iloperidone</td>
		<td>Aripirazole</td>
		<td>Lurasidone</td>
		<td>Risperidone</td>
		<td>Haloperidol</td>
		<td>Asenpaine</td>
		<td>Olan/apine</td>
		<td>Quetiapine</td>
		<td>Ziprasidone</td>
	</tr>
	<tr>
		<td></td>
		<td></td>
		<td></td>
		<td></td>
		<td></td>
		<td></td>
		<td></td>
		<td></td>
		<td></td>
		<td></td>
		<td></td>
		<td></td>
	</tr>
</table>
<p>zyprexa = hyperlipidemia, hyperglycemia</p>
<p>Is diabetes risk solely based on weight or something else?</p>
<p>NMS</p>
<p>For example is it </p>
<table width="595" border="1" cellspacing="2" cellpadding="0">
	<tr>
		<td>Receptor Type</td>
		<td>Adverse Effects</td>
		<td>Withdrawal Effects</td>
	</tr>
	<tr>
		<td>Dopamine</td>
		<td>EPS, weight gain, endocrine effects, akathisia, TD, increased prolactin, sexual or reproductive system dysfunction</td>
		<td>Pychosis, mania, agitation, akathisia, dyskinesia</td>
	</tr>
	<tr>
		<td>Serotonin</td>
		<td>Weight gain, diabetes, increased appetite</td>
		<td>EPS, akathisia, psychosis, decrease apetite</td>
	</tr>
	<tr>
		<td>Histamine</td>
		<td>Weight gain, diabetes, sedation</td>
		<td>agitation, insomnia, anxiety, EPS</td>
	</tr>
	<tr>
		<td>Muscarinic</td>
		<td>Dry mouth, blurred vision, constipation, urinary retention, diabetes, memory problems, cognitive problems, tachycardia, hypertension</td>
		<td>Agitation, confusion, psychosis, anxiety, insomnia, sialorrhea, EPS, akathisia, diarhea, nausea, vomiting, bradycardia, hypotension, syncope</td>
	</tr>
	<tr>
		<td>Adrenergic</td>
		<td>Postural hypotension, dizziness, syncope</td>
		<td>Tachycardia, hypertension, hypotension, dizziness</td>
	</tr>
</table>
<p>Mechanisms behind receptor-mediated psychotropic-induced weight effects</p>
<table width="766" border="1" cellspacing="2" cellpadding="0">
	<tr>
		<td>Receptor</td>
		<td>Activity</td>
		<td>Effects/Mechanism</td>
		<td>receptor name</td>
	</tr>
	<tr>
		<td>Dopamine-2</td>
		<td>Antagonism</td>
		<td>Weight gain</td>
		<td>d</td>
	</tr>
	<tr>
		<td>Histamine-1</td>
		<td>Antagonism</td>
		<td>Weight gain</td>
		<td>h</td>
	</tr>
	<tr>
		<td>Murscarinic-3</td>
		<td>Antagonism</td>
		<td>diabetes via glucose tolerance</td>
		<td>m</td>
	</tr>
	<tr>
		<td>Serontonin-1A</td>
		<td>Partial agonism</td>
		<td>migigate weight effects</td>
		<td>5-HT<sub>1A</sub></td>
	</tr>
	<tr>
		<td>Serotonin-2C</td>
		<td>Antagonism</td>
		<td>causes weight gain via disinhibition of hpythalamic neuropeptide Y neurons and inhibition of pro-opiomelanocortin neurons; may also influence leptin restistance</td>
		<td>5-HT<sub>2C</sub>
		</td>
	</tr>
</table>
<p></p>
<p>Relative affinity for H1 Receptors (100)</p>
<table border="1" cellspacing="2" cellpadding="0" class="bargraph">
	<tr>
		<td>100</td>
		<td>10</td>
		<td>4.99</td>
		<td>1.6</td>
		<td></td>
	</tr>
	<tr>
		<td>Doxepin</td>
		<td>Amitriptyline</td>
		<td>Antidepressants</td>
		<td>Trazodone</td>
		<td></td>
	</tr>
</table>
<p>Atypical Agents and Histamine H1 Receptor Blockade</p>
<table border="1" cellspacing="2" cellpadding="0" class="bargraph">
	<tr>
		<td>7.1</td>
		<td>1.7</td>
		<td>9.1</td>
		<td>14</td>
		<td>36</td>
	</tr>
	<tr>
		<td>Benadryl</td>
		<td>Risperidone</td>
		<td>Seroquel</td>
		<td>Zyprexa</td>
		<td>Clozapine</td>
	</tr>
</table>
<p>EPS = extrapymadil symptoms.  Source C Correll, &quot;Assessing and maximizing the safety and tolerability of antipsychotics used in treatment of children and adolescents.&quot; J Chin Psychiatry 69, suppl. 4 (2008) 26-36. Also see C. Cornell, &quot;Antipsychotics use in children and adolescents.&quot; J Am Acad Child Adols Psychiatry.47 (2008) 9-20</p>
<p>Richmond Agitation Sedation Scale</p>

<p>

“I have struggled with having a mental illness since my teenage years. Currently I am 51 years old. Initially I was diagnosed with depression, but even with medications, my illness worsened, and in time I was having bipolar mood swings and psychotic symptoms.

My illness turned my life upside down and estranged me from my family and friends. In August, 2010, my husband called Dr. Alice Lee-Bloem for help, because I was deteriorating after trying to get off my medications (Lithium, Zyprexa, Prozac, and Lipitor) through “True Hope”, a nutritional company, that had success in using their nutritional products, E. M. Power Plus and other supplements, to help bipolar patients get off their medications long distance. Initially, I had done well, but in time, my mental health deteriorated to the point that I was almost in need of being hospitalized. I was psychotic and unable to sleep. I was also very irritable and paranoid of everyone around me.

Dr. Lee told me to get back on some medication to restabilize me. I was started on Risperdal, and it helped me enough to prevent the need to rehospitalize me. Then she started me on a nutritional regimen and did a lot of energy medicine work on me. Over time, my sleep, mood, and cognitive functions improved, and I was able to start weaning down on my Risperdal. As I came down on Risperdal, I transitioned to a small dosage of liquid Haldol. Eventually, I was able to get off of the Haldol completely as well.
</p><p>I did an analysis, using muscle testing, to check for the patient’s qualitative function, and the results indicated that the patient was on too much medication, not too little.  I had been too conservative with the taper and not aggressive enough.  This was it.  After six months of treatment, we would need to stop the remaining 0.3 mg of Risperdal.  To do so would go against my training and would require courage and faith in following the testing results.  I shared my results and conclusion with the family and patient, looking a little concerned, worried and apologetic.</p>
Switching Drugs Risperidone
<table width="431" border="1" cellspacing="2" cellpadding="0">
	<tbody><tr>
		<td></td>
		<td>Risperidone</td>
		<td>Seroquel</td>
		<td>Olanzapine</td>
		<td>Clozapine</td>
		<td>Solian</td>
		<td>Abilify</td>
		<td>Geodon</td>
		<td>Haldol</td>
		<td>Doxepin</td>
		<td>Remeron</td>
		<td>Elavil</td>
		<td>Trazodone</td>
	</tr>
	<tr>
		<td>Risperidone</td>
		<td>++</td>
		<td>++</td>
		<td>++</td>
		<td>++</td>
		<td>+</td>
		<td>++</td>
		<td></td>
		<td></td>
		<td>+/-</td>
		<td></td>
		<td>+</td>
		<td>low</td>
	</tr>
	<tr>
		<td>Seroquel</td>
		<td>-</td>
		<td>+</td>
		<td>++</td>
		<td>+++</td>
		<td>++</td>
		<td>++</td>
		<td></td>
		<td></td>
		<td>+/-</td>
		<td>-</td>
		<td>+</td>
		<td>2</td>
	</tr>
	<tr>
		<td>Olanzapine</td>
		<td>+</td>
		<td>+++</td>
		<td>+++</td>
		<td>+++</td>
		<td>+++</td>
		<td>+</td>
		<td></td>
		<td></td>
		<td>+</td>
		<td>-</td>
		<td>+</td>
		<td>low</td>
	</tr>
	<tr>
		<td>Clozapine</td>
		<td>+</td>
		<td>+++</td>
		<td>+++</td>
		<td>+++</td>
		<td>+++</td>
		<td>++</td>
		<td></td>
		<td></td>
		<td></td>
		<td></td>
		<td></td>
		<td></td>
	</tr>
	<tr>
		<td>Solian</td>
		<td>++</td>
		<td>+</td>
		<td>+</td>
		<td>+</td>
		<td>+</td>
		<td>+</td>
		<td></td>
		<td></td>
		<td></td>
		<td></td>
		<td></td>
		<td></td>
	</tr>
	<tr>
		<td>Abilify</td>
		<td>+</td>
		<td>+</td>
		<td>+</td>
		<td>+</td>
		<td>+</td>
		<td>+</td>
		<td></td>
		<td></td>
		<td></td>
		<td></td>
		<td>-</td>
		<td>-</td>
	</tr>
	<tr>
		<td>Geodon&nbsp;</td>
		<td>+</td>
		<td>++</td>
		<td>+</td>
		<td>+</td>
		<td>+</td>
		<td>++</td>
		<td></td>
		<td></td>
		<td></td>
		<td></td>
		<td></td>
		<td></td>
	</tr>
	<tr>
		<td>haldol</td>
		<td></td>
		<td></td>
		<td></td>
		<td></td>
		<td></td>
		<td></td>
		<td></td>
		<td></td>
		<td></td>
		<td></td>
		<td></td>
		<td></td>
	</tr>
	<tr>
		<td>doxepin</td>
		<td></td>
		<td></td>
		<td></td>
		<td></td>
		<td></td>
		<td></td>
		<td></td>
		<td></td>
		<td></td>
		<td></td>
		<td></td>
		<td>1</td>
	</tr>
	<tr>
		<td>remeron</td>
		<td></td>
		<td></td>
		<td></td>
		<td></td>
		<td></td>
		<td></td>
		<td></td>
		<td></td>
		<td></td>
		<td></td>
		<td></td>
		<td>high</td>
	</tr>
	<tr>
		<td>elavil</td>
		<td></td>
		<td></td>
		<td></td>
		<td></td>
		<td></td>
		<td></td>
		<td></td>
		<td></td>
		<td></td>
		<td></td>
		<td></td>
		<td>4</td>
	</tr>
	<tr>
		<td>trazodone</td>
		<td></td>
		<td></td>
		<td></td>
		<td></td>
		<td></td>
		<td></td>
		<td></td>
		<td></td>
		<td></td>
		<td></td>
		<td></td>
		<td></td>
	</tr>
</tbody></table>
<pre>
Valid ID, such as

Driver’s license
Employment or School ID
Social Security card
Green Card
Valid Passport
Veteran’s ID
Insurance card or Medical card (if you have one)

Proof of income for every household member,
Which may include
a paycheck stub OR
a copy of your tax form reporting your income OR
a bank statement if you receive direct deposit
Proof of residence, for example, a bill addressed to you sent by mail
Evidence of health or dental insurance coverage, if any
A picture ID card
</pre><img width="500" src="https://www.bellinghamosteopathiccenter.com/wp-content/uploads/comparision-chart.png">
<p>Different names for holistic types of medicine across the world</p>
<table width="708" border="1" cellspacing="2" cellpadding="0">
	<tr>
		<td></td>
		<td>holistic</td>
		<td>alternative</td>
		<td>integrative</td>
		<td>natural</td>
		<td>homeopathic</td>
		<td>naturopaths</td>
	</tr>
	<tr>
		<td>holistic</td>
		<td></td>
		<td></td>
		<td></td>
		<td></td>
		<td></td>
		<td></td>
	</tr>
	<tr>
		<td>alternative</td>
		<td></td>
		<td>acupnture</td>
		<td></td>
		<td></td>
		<td></td>
		<td></td>
	</tr>
	<tr>
		<td>integrative</td>
		<td></td>
		<td></td>
		<td>surgery<br>
			pharmaceuticals<br>
			herbs<br>
			chirpractic</td>
		<td></td>
		<td></td>
		<td></td>
	</tr>
	<tr>
		<td>natural</td>
		<td></td>
		<td></td>
		<td></td>
		<td>herbs<br>
			massage<br>
			acupuncture</td>
		<td></td>
		<td></td>
	</tr>
	<tr>
		<td>homeopathic</td>
		<td></td>
		<td></td>
		<td></td>
		<td></td>
		<td>europe &amp; india</td>
		<td></td>
	</tr>
	<tr>
		<td>naturopaths</td>
		<td></td>
		<td></td>
		<td></td>
		<td></td>
		<td></td>
		<td></td>
	</tr>
</table>
<p>
Nutrition based treatments: GERD, Kidney Stones, T2D 

</p>
